Refinement of polyclonal antibody production by combining oral immunization of chickens with harvest of antibodies from the egg yolk

ILAR Journal

Volumn 46, Issue 3, 2005, Pages 294-299

  Hau, Jann ^a   Hendriksen, Coenraad F M ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NETHERLANDS VACCINE INSTITUTE   (Netherlands)

Author keywords

Adjuvant; Chicken; Egg yolk; Immune system; Immunization; Oral; Polyclonal antibody; Three Rs

Indexed keywords

CHOLERA TOXIN; FREUND ADJUVANT; IMMUNOGLOBULIN Y; IMMUNOLOGICAL ADJUVANT; POLYCLONAL ANTIBODY;

ANIMAL TESTING REDUCTION; ANIMAL TESTING REFINEMENT; ANIMAL TESTING REPLACEMENT; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; BLOOD SAMPLING; CELLULAR IMMUNITY; CHICKEN; EXPERIMENTAL ANIMAL; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; NONHUMAN; RESEARCH ETHICS;

ANIMALIA; AVES; GALLUS GALLUS; MAMMALIA;

EID: 21044433919     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.46.3.294     Document Type: Article

References (49)

1. Ameiss KA, Danforth HD, McElroy AP, Barri A, Berghman LR, Caldwell DJ. 2004. Immunogenicity of ad libitum drinking water administration of bovine serum albumin in Leghorn chickens. Poult Sci 83:1535-1538.
2. Bergerot I, Ploix C, Petersen J, Moulin V, Rask C, Fabien N, Lindblad M, Mayer A, Czerkinsky C, Holmgren J, Thivolet C. 1997. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc Natl Acad Sci U S A 94:4610-4614.
3. Bergquist C, Lagergard T, Holmgren J. 1997. Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate. Infect Immun 65:1579-1583.
4. Bizhanov G, Jonauskiene I, Hau J. 2004. A novel method based on lithium sulfate precipitation for purification of chicken egg yolk immunoglobulin Y, applied to iminunospecific antibodies against Sendai virus. Scand J Lab Anim Sci 31:121-130.
5. Bollen LS, Hau J. 1996. Chicken eggs in polyclonal antibody production. In: Nevalainen T, Hau J, Sarviharju M, eds. Proceedings of the 10th ICLAS Meeting, Helsinki, Finland, July 1995. Scand J Lab Anim Sci Suppl 1.
6. Bollen LS, Hau J. 1997. Immunoglobulin G in the developing oocytes of the domestic hen and immunospecific antibody response in serum and corresponding egg yolk. In Vivo 11:395.
7. Bollen LS, Hau J. 1999a. Comparison of immunospecific antibody response in young and old chickens immunised with human IgG. Lab Anim 33:71-76.
8. Bollen LS, Hau J. 1999b. Freund's complete adjuvant has a negative impact on egg laying frequency in immunised chickens. In Vivo 13:107-108.
9. Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, Weiner HL. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177-189.
10. Czerkinsky C, Russell MW, Lycke N, Lindblad M, Holmgren J. 1989. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect Immun 57:1072-1077.
11. de Geus B, Dol-Bosman M, Scholten JW, Stok W, Bianchi A. 1997. A comparison of natural and recombinant cholera toxin B subunit as stimulatory factors in intranasal immunization. Vaccine 15:1110-1113.
12. George-Chandy A, Eriksson K, Lebens M, Nordstrom I, Schon E, Holmgren J. 2001. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infect Immun 69:5716-5725.
13. Hanly WC, Artwohl JE, Bennett BT. 1995. Review of polyclonal antibody production procedures in mammals and poultry. ILAR News 37:93.
14. Hau J, Westergaard JG, Svendsen P, Bach A, Teisner B. 1980. Comparison between pregnancy-associated murine protein-2 (PAMP-2) and human pregnancy-specific beta 1-glycoprotein (SP-1). J Reprod Fertil 60:115.
15. Hau J, Westergaard JG, Svendsen P, Bach A, Teisner B. 1981. Comparison of the pregnancy-associated murine protein-1 and human pregnancy zone protein. J Reprod Immunol 3:341.
16. Hedlund GP, Hau J. 2001. Oral immunisation of chickens using cholera toxin B subunit and Softigen as adjuvants results in high antibody titre in the egg yolk. In Vivo 15:381-384.
17. Hendriksen C, Hau J. 2003. Production of monoclonal and polyclonal antibodies. In: Hau J, Van Hoosier G, eds. Handbook in Laboratory Animal Science. Vol I: Essential Principles and Practices. Boca Raton: CRC Press. p 391-412.
18. Holmgren J, Czerkinsky C, Sun JB, Svennerholm AM. 1996. Oral vaccination, mucosal immunity and oral tolerance with special reference to cholera toxins. In: Kaufmann SHE, ed. Concepts in Vaccine Development. Berlin: Walter de Gruyter. p 437-458.
19. Jensenius JC, Andersen I, Hau J, Crone M, Koch C. 1981. Eggs: Conveniently packaged antibodies. Methods for purification of yolk IgG. J Immunol Methods 46:63.
20. Jertborn M, Nordstrom I, Kilander A, Czerkinsky C, Holmgren J. 2001. Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans. Infect Immun 69:4125-4128.
21. Jertborn M, Svennerholm AM, Holmgren J. 1993. Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine 11:1007-1112.
22. Kang SM, Yao Q, Guo L, Compans RW. 2003. Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit Br J Virol 77:9823-9830.
23. Klipper E, Sklan D, Friedman A. 2001. Response, tolerance and ignorance following oral exposure to a single dietary protein antigen in Gallus domesticus. Vaccine 19:2890-2897.
24. Larsson A, Karlsson-Parra A, Sjoquist J. 1991. Use of chicken antibodies in enzyme immunoassays to avoid interference by rheumatoid factors. Clin Chem 37:211-215.
25. Leenaars M, Claassen E, Boersma WJA. 1996. Modulation of the humoral immune response: Antigens and antigen presentation. In: Lefkovits I, ed. Immunology Methods Manual. London: Academic Press Ltd. p 989.
26. Leenaars, M, Hendriksen CFM. 2005. Critical steps in the production of polyclonal and monoclonal antibodies: Evaluation and recommendations, ILAR J 46:269-279.
27. Leenaars PPAM, Hendriksen CFM, De Leeuw WA, Carat F, Delahaut P, Fischer R, Halder M, Hanley WC, Hartinger J, Hau J, Lindblad EB, NicklasW, Outschoorn IM, Stewart-Tull ES. 1999. The production of polyclonal antibodies in laboratory animals. ATLA 27:79.
28. Lindblad EB, Hau J. 2000. Escaping from the use of Freund's complete adjuvant. In: Balls M, van Zeller A-M, eds. Progress in the Reduction, Refinement and Replacement of Animal Experimentation. Proceedings from the 3rd World Congress on Alternatives and Animal Use in the Life Sciences of 1999. Amsterdam: Elsevier. p 1681-1685.
29. Lycke N. 1997. The mechanism of cholera toxin adjuvanticity. Res Immunol 148:504-520.
30. MacDonald TT. 1982. Enhancement and suppression of the Peyer's patch immune response by systemic priming. Clin Exp Immunol 49:441.
31. Matzinger P. 1994. Tolerance, danger, and the extended family. Annu Rev Immunol 12:991-1045.
32. Mayo SL, Persdotter-Hedlund G, Tufvesson M, Hau J. 2003. Systemic immune response of young chickens orally immunized with bovine serum albumin. In Vivo 17:261-268.
33. Mayo SL, Royo F, Hau J. 2005. Correlation between adjuvanticity and immunogenicity of cholera toxin B-subunit in orally immunised young chickens. APMIS (Acta Pathologica, Microbiologica et Immunologica Scandinavica) (In Press).
34. McCullough KC, Hendriksen CFM, Seeback T. 1997. In vitro methods in Vaccinology. In: Pastoret P-P, Blancou J, Vannier P, Verschueren C, eds. Veterinary Vaccinology. Amsterdam: Elsevier. p 69.
35. Mine Y, Kovacs-Nolan J. 2002. Chicken egg yolk antibodies as therapeutics in enteric infectious disease: A review. J Med Food 5:159-169.
36. Nashar TO, Webb HM, Eaglestone S, Williams NA, Hirst TR. 1996. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: Receptor binding is essential and induces differential modulation of lymphocyte subsets. Proc Natl Acad Sci U S A 9:226-230.
37. Nielsen BR, Poulsen OM, Hau J. 1989. Reagin production in mice: Effect of subcutaneous and oral sensitization with untreated bovine milk and homogenized bovine milk. In Vivo 3:271-274.
38. Persdotter Hedlund G, Hau J. 2001. Oral immunization of chickens using cholera toxin B subunit and Softigen as adjuvants results in high antibody titre in the egg yolk. In Vivo 15:384.
39. Poulsen OM, Hau J, Kollerup J. 1987. Effect of homogenization and pasteurization on the allergenicity of bovine milk analysed by a murine anaphylactic shock model. Clin Allergy 17:449-458.
40. Russell WMS, Burch RL. 1959. The Principles of Humane Experimental Technique. London: Methuen & Co LTD.
41. Schade R, Staak C, Hendriksen C, Erhard M, Hugl H, Koch G, Larsson A, Pollmann W, van Regenmortel M, Rijke E, Spielmann H, Steinbusch H, Straughan D. 1996. The production of avian (egg yolk) antibodies: IgY. ECVAM Workshop Report 21. ATLA 24:925.
42. Schade R, Behn I, Erhard M, Hlinak A, Staak C, eds. 2001. Chicken Egg Yolk Antibodies, Production and Application. IgY-Technology. Berlin: Springer Lab Manual.
43. Sun JB, Holmgren J, Czerkinsky C. 1994. Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci U S A 91:10795-10799.
44. Svendsen L, Crowley A, Ostergaard LH, Stodulski G, Hau J. 1995. Development and comparison of purification strategies for chicken antibodies from egg yolk. Lab Anim Sci 45:89-93.
45. Svendsen Bollen L, Crowley A, Stodulski G, Hau J. 1996. Antibody production in rabbits and chickens immunized with human IgG. A comparison of titre and avidity development in rabbit serum, chicken serum and egg yolk using three different adjuvants. J Immunol Methods 27: 113-120.
46. Takada A, Kida H. 1996. Protective immune response of chickens against Newcastle disease, induced by the intranasal vaccination with inactivated virus. Vet Microbiol 50:17-25.
47. Tochikubo K, Isaka M, Yasuda Y, Kozuka S, Matano K, Miura Y, Taniguchi T. 1998. Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin. Vaccine 16:150-155.
48. von Behring E, Kitasato S. 1890. Uber das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Tieren. [Production of diphtheria immunity and tetanus immunity in animals]. Deutsche Medizinische Wochenschrift 49:113.
49. Yuki Y, Kiyono H. 2003. New generation of mucosal adjuvants for the induction of protective immunity. Rev Med Virol 13:293-310.